Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vistagen Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
VTGN
Nasdaq
8731
https://www.vistagen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vistagen Therapeutics Inc
30 Countries with the Lowest Depression Rates
- Mar 26th, 2024 10:24 am
Vistagen to Present at Stifel 2024 Virtual CNS Days
- Mar 11th, 2024 12:30 pm
Vistagen to Present at TD Cowen 44th Annual Health Care Conference
- Feb 28th, 2024 1:30 pm
Does VistaGen Therapeutics, Inc. (VTGN) Have the Potential to Rally 160% as Wall Street Analysts Expect?
- Feb 21st, 2024 2:55 pm
3 Revolutionary Biotech Stocks Poised for 10X Surge
- Feb 19th, 2024 5:24 pm
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript
- Feb 15th, 2024 1:20 pm
Vistagen Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
- Feb 15th, 2024 10:47 am
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
- Feb 14th, 2024 8:45 pm
Vistagen Therapeutics Inc (VTGN) Reports Fiscal 2024 Q3 Results: A Closer Look at Financials ...
- Feb 13th, 2024 9:59 pm
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
- Feb 13th, 2024 9:20 pm
3 Penny Stocks to Buy for the Next Bull Run: February 2024
- Feb 7th, 2024 12:38 pm
Vistagen to Report Fiscal Year 2024 Third Quarter Financial Results and Host Corporate Update Conference Call on February 13, 2024
- Feb 6th, 2024 1:30 pm
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?
- Feb 1st, 2024 10:16 am
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
- Jan 26th, 2024 2:04 pm
How Vistagen (VTGN) Stock Stands Out in a Strong Industry
- Dec 29th, 2023 1:40 pm
Vistagen Receives Notice from European Patent Office of Intention to Grant Patent for AV-101 to Treat Neuropathic Pain
- Dec 27th, 2023 1:30 pm
11 Most Promising Psychedelic Stocks According to Hedge Funds
- Dec 20th, 2023 7:15 pm
Retail investors are Vistagen Therapeutics, Inc.'s (NASDAQ:VTGN) biggest owners and were rewarded after market cap rose by US$12m last week
- Nov 29th, 2023 10:37 am
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q2 2024 Earnings Call Transcript
- Nov 11th, 2023 6:03 pm
Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results
- Nov 9th, 2023 9:30 pm
Scroll